Metformin may reduce side effects of systemic steroids: study

Small trial shows better glucose, lipids and stabilisation of insulin resistance

Metformin reduces the metabolic complications of systemic glucocorticoid therapy while preserving its anti-inflammatory benefits, according to results from a proof-of-concept phase-2 trial.